Bio-Reference Labs (BRLI) Tops Q2 EPS by 2c
More News related to BRLI
- AirClic Mobile Business Solutions 'Clic' for Bio-Reference Laboratories, Inc.
- BioReference Laboratories, Inc. to Speak at the Jefferies 3rd Annual Healthcare Conference
- BioReference Laboratories, Inc to speak at the William Blair 29th Annual Growth Stock Conference
- Jefferies & Co Downgrades Bio-Reference Labs (BRLI) to Hold
- Morning Movers 6/4: WIND, NVAX, OCLS, AGEN, CONN, ATSI Higher; OMEX, BGP, CODI, GU, ANF Lower
Bio-Reference Labs (Nasdaq: BRLI) reports Q2 earnings of $0.34 per share, above the consensus of $0.32. Revenues came in at $77.8 million, versus the consensus of $77.9 million.
Bio-Reference Laboratories, Inc. provides clinical laboratory testing services primarily in the greater New York metropolitan area.
Related Categories
EarningsStocks Mentioned
-1.83Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
